Heidelberg Pharma AG - Strategy, SWOT and Corporate Finance Report

Heidelberg Pharma AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Heidelberg Pharma AG (Heidelberg Pharma) formerly, Wilex AG is a biopharmaceutical company. The company develops therapeutic and diagnostic product candidates for the treatment and specific detection of various cancers. Heidelberg Pharma’s pipeline products are focused on treating multiple myeloma, prostate cancer, hematological cancers, metastatic pancreatic cancers, leukemia, non- metastatic ccRCC, kidney cancers and solid tumors. Through its subsidiary Heidelberg Pharma Research GmbH provides preclinical contract research services and is the first company to develop the toxin Amanitin into oncology therapies using its proprietary Antibody Targeted Amanitin Conjugate (ATAC) technology platform. Heidelberg Pharma is headquartered in Ladenburg, Germany.

Scope

  • Detailed information on Heidelberg Pharma AG required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Heidelberg Pharma AG in the form of a SWOT analysis
  • An in-depth view of the business model of Heidelberg Pharma AG including a breakdown and examination of key business segments
  • News about Heidelberg Pharma AG, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

  • Gain understanding of Heidelberg Pharma AG and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Heidelberg Pharma AG as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Heidelberg Pharma AGs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Navigo Proteins GmbH

Merck KGaA

MediGene AG

Epigenomics AG

Biotest AG

Baxter Oncology GmbH

4SC AG

Navigo Proteins GmbH

Merck KGaA

MediGene AG

Epigenomics AG

Biotest AG

Baxter Oncology GmbH

4SC AG

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Heidelberg Pharma AG - Key Facts

Heidelberg ...

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Heidelberg Pharma AG - Key Facts

Heidelberg Pharma AG - Key Employees

Heidelberg Pharma AG - Key Employee Biographies

Heidelberg Pharma AG - Major Products and Services

Heidelberg Pharma AG - History

Heidelberg Pharma AG - Company Statement

Heidelberg Pharma AG - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Heidelberg Pharma AG - Business Description

Heidelberg Pharma AG - Corporate Strategy

Heidelberg Pharma AG - SWOT Analysis

SWOT Analysis - Overview

Heidelberg Pharma AG - Strengths

Heidelberg Pharma AG - Weaknesses

Heidelberg Pharma AG - Opportunities

Heidelberg Pharma AG - Threats

Heidelberg Pharma AG - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Heidelberg Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Heidelberg Pharma AG, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Heidelberg Pharma AG, Recent Deals Summary

Section 5 – Company’s Recent Developments

Jul 11, 2019: Heidelberg Pharma reports on first half-year

May 21, 2019: Heidelberg Pharma reports outcome of annual general meeting

Apr 11, 2019: Heidelberg pharma: Interim management statement on the first three months of 2019

Mar 27, 2019: Heidelberg Pharma to present its proprietary ATAC technology platform at the AACR Annual Meeting 2019

Mar 21, 2019: Heidelberg Pharma announces financial figures for fiscal year 2018 and provides business update

Oct 19, 2018: WILEX successfully completes change of name to Heidelberg Pharma

Oct 11, 2018: Heidelberg Pharma AG: Interim management statement on the first nine months of 2018

Jul 12, 2018: Heidelberg Pharma reports on first half -year

Apr 12, 2018: Heidelberg Pharma: Interim Management Statement on the First Three Months of 2018

Apr 09, 2018: Heidelberg Pharma Presents Proprietary ATAC Technology Platform at Two Scientific Conferences

Section 6 – Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Heidelberg Pharma AG, Key Facts

Heidelberg Pharma AG, Key Employees

Heidelberg Pharma AG, Key Employee Biographies

Heidelberg Pharma AG, Major Products and ...

List of Tables

Heidelberg Pharma AG, Key Facts

Heidelberg Pharma AG, Key Employees

Heidelberg Pharma AG, Key Employee Biographies

Heidelberg Pharma AG, Major Products and Services

Heidelberg Pharma AG, History

Heidelberg Pharma AG, Subsidiaries

Heidelberg Pharma AG, Key Competitors

Heidelberg Pharma AG, Ratios based on current share price

Heidelberg Pharma AG, Annual Ratios

Heidelberg Pharma AG, Annual Ratios (Cont...1)

Heidelberg Pharma AG, Interim Ratios

Heidelberg Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Heidelberg Pharma AG, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Heidelberg Pharma AG, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Heidelberg Pharma AG, Performance Chart (2014 - 2018)

Heidelberg Pharma AG, Ratio Charts

Heidelberg Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, ...

List of Figures

Heidelberg Pharma AG, Performance Chart (2014 - 2018)

Heidelberg Pharma AG, Ratio Charts

Heidelberg Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Heidelberg Pharma AG, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports